What Zorgvuldig Advies does

Zorgvuldig Advies B.V. is a privately held Dutch healthcare consulting firm founded in 2010 and headquartered in Utrecht. The firm operates with four partners and approximately ten advisors, supplemented by a network of associates and partner firms, providing three core service lines: strategic advisory, policy and applied research, and training/masterclasses for healthcare professionals and policymakers. Its primary clients are Dutch public-sector bodies (Ministry of VWS, ACM, NZa, Zorginstituut Nederland, municipalities), health insurers (including DSW and the Zorgverzekeraars Nederland collective), and care provider organizations (such as Reinier de Graaf Gasthuis). The firm holds a long-running coordination mandate as 'Kwartiermaker Transgenderzorg' since 2018 and a tranchemanager role in the Waardigheid en Troots voor de Toekomst program, which has supported over 140 care organizations.

The business model is project-based professional services, with fees generated through commission-based mandates, tenders, and referrals. Pricing is generally quote-driven across advisory, research, and training engagements. The firm has productized one asset—Het Trendspel, a card-based facilitation tool of approximately 100 cards covering five categories of Dutch healthcare trends, sold standalone at €99 excluding VAT or bundled with a facilitated session starting at €299 excluding VAT. In November 2023, Zorgvuldig Advies established a joint venture called Zorgvuldig Digitaal with Inkubis to provide independent digital transition support for healthcare organizations, covering data use, digital collaboration, and responsible AI adoption; this is the firm's principal productized extension beyond core advisory.

Zorgvuldig Advies does not develop proprietary software. Its technology footprint is limited to internal AI-assisted productivity tools: Dembrane, a Dutch ethical AI platform used for recording, transcribing, and summarizing complex conversations, and Claude from Anthropic, used for research and text preparation. The firm's distribution is entirely direct, with no resellers or marketplace presence, and its geographic scope is restricted to the Netherlands. Thought leadership (website blog, Zorgvisie.nl articles, media commentary by partners) and direct outreach to a long-standing government and insurer network constitute the core go-to-market motion.

Name

Zorgvuldig Advies

Legal name

Zorgvuldig Advies B.V.

Website

https://zorgvuldigadvies.nl

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Zorgvuldig Advies is a Dutch healthcare consulting firm founded in 2010 that provides strategic advisory, policy research, and training services to government bodies, health insurers, and healthcare organizations across the Netherlands.

Ownership category

akta.pro rank

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Strategic Advisory Services: Core consulting engagements advising healthcare organizations on strategy, policy, regulation, and organizational change. Revenue generated through project-based fees for advisory mandates from government ministries, health insurers, municipalities, and healthcare providers.
2. Research Services: Commissioned research projects to ground policy and strategic decisions. Conducted for government bodies (Ministry of VWS), regulators (NZa, ACM), and healthcare organizations. Project-based fees.
3. Training and Masterclasses: Training programs for healthcare professionals, physicians, pharmacists, and policymakers, including (online and offline) masterclasses on healthcare finance, the Dutch health system, and demographic/technological/political trends. Also developing curricula (leergangen).
4. Trendspel Product Sales: Sale of the Trendspel card game (approximately 100 cards on healthcare sector trends) as a standalone product (€99 excl. VAT) or bundled with a facilitated session led by a Zorgvuldig Advies advisor (starting at €299 excl. VAT).

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Zorgvuldig Advies is a Dutch healthcare consulting firm that delivers strategic advisory, policy research, and training services to healthcare organizations, government bodies, health insurers, and municipalities. Core engagements focus on healthcare financing, regulation, reimbursement reform, and organizational transformation. The firm also distributes the Trendspel card-based workshop tool and coordinates the national Kwartiermaker Transgenderzorg program.

Product overview

Zorgvuldig Advies is a healthcare advisory firm offering consulting, research, and training services delivered by a team of approximately ten advisors. It does not operate a unified software product or platform; its offerings are service-based. The core portfolio consists of advisory services (strategic and policy advice), research services (qualitative and quantitative), and training programs for healthcare professionals. Notable specific offerings include the Trendspel card-based workshop tool, the Kwartiermaker Transgenderzorg coordination program (since 2018), and Zorgvuldig Digitaal (a joint venture with Inkubis launched in 2023 for digital healthcare transition). AI tools such as Dembrane and Claude are used internally to support advisory delivery but are not sold as standalone products.

Differentiator

Problem solved

Functional benefit

Brands

• Zorgvuldig Digitaal: An independent and reliable partner to enable digital transition in healthcare, established as a joint venture with Inkubis
• Trendspel

Quantifiable outcome

• Research projected SOV savings of €3.3M–€10.4M per year by 2028 through programs for short-term shelter for homeless EU citizens and Housing First/Wonen Eerst.
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature1 record

Partnerships

Twelve partnerships are on record, tiered core and minor.

• InkubiscoreStrategic or Co-development Partner · 14 November 2023Zorgvuldig Advies and Inkubis jointly founded Zorgvuldig Digitaal as an independent and reliable partner to enable digital transition in healthcare. Zorgvuldig Digitaal combines healthcare domain knowledge and IT expertise, leveraging an ecosystem of experts to help healthcare organizations overcome economic, legal, organizational, and ethical barriers to digital transformation.
• BerenschotcoreStrategic or Co-development Partner · 16 December 2021Zorgvuldig Advies collaborated with Berenschot on a research project for the Ministry of VWS examining the 'bottom of the pharmaceutical market.' The study developed a definition and description of this market segment and analyzed the influence of instruments, policy, and behavior on it. The resulting report was submitted to the Tweede Kamer.
• BerenschotcoreStrategic or Co-development Partner · 22 February 2021Zorgvuldig Advies and Berenschot jointly conducted research on whether a 'sluis' (gateway mechanism) for MedTech market entry is needed in the Netherlands. The report was submitted to the Tweede Kamer and informed the Raemakers motion.
• jb LorenzminorStrategic or Co-development Partner · 1 January 2018Zorgvuldig Advies worked with jb Lorenz (an expert in decentralized healthcare procurement and reimbursement) to conduct research for the ACM on market conditions in decentralized healthcare under the Jeugdwet and Wmo 2015, and the consequences for competition.
• TransvisieminorStrategic or Co-development PartnerZorgvuldig Advies collaborated with transgender organization Transvisie, along with scientists from Amsterdam UMC and Radboudumc, to conduct a comprehensive survey-based study (2022) on the experiences and needs of people who have received or are waiting for transgender healthcare.
• Vrije Universiteit AmsterdamminorStrategic or Co-development PartnerPiet de Bekker, partner at Zorgvuldig Advies, conducts research at the Vrije Universiteit in Amsterdam, combining insights from research (science), practice, policy, and entrepreneurship.
• DembranecoreTechnology or IntegrationDembrane is a Dutch ethical AI company based in Eindhoven that meets the strictest European requirements for data security and ethical, sovereign AI use. Zorgvuldig Advies uses Dembrane as their primary tool for recording and summarizing complex conversations, noting it as AVG (GDPR)-compliant with servers in Europe. Zorgvuldig Advies has a partnership with Dembrane and describes itself as a 'partner' and user.
• Zorginstituut NederlandminorStrategic or Co-development PartnerZorgvuldig Advies wrote a background study for the Zorginstituut Nederland's Monitor Weesgeneesmiddelen (Orphan Drugs Monitor) 2020, focusing on the accessibility of non-oncological orphan drugs.
• PanaxeaminorStrategic or Co-development PartnerZorgvuldig Advies collaborated with research bureau Panaxea on a study for Zorginstituut Nederland regarding care at audiologists for adults with perceptive hearing loss.
• Andersson Elffers Felix (AEF)minorImplementation/ SI/ Consulting PartnerAEF conducted research on infectious disease control (IZB) capacity at GGDs with support from Zorgvuldig Advies consultant Laura Blomaard who was part of the research team.
• Vereniging Nederlandse Gemeenten (VNG)minorStrategic or Co-development PartnerZorgvuldig Advies collaborated with VNG, knowledge institute Movisie, and healthcare providers Check-in Coaching, Jonx, and Genderteam Zuid-Nederland to develop the Handreiking Transgenderzorg voor Gemeenten.
• MovisieminorStrategic or Co-development PartnerKnowledge institute collaborating with Zorgvuldig Advies on the Handreiking Transgenderzorg voor Gemeenten.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• BMC: Dutch public-sector and healthcare consultancy with deep municipal and ministry relationships. Ed Maagdelijn is a former BMC employee. Overlaps directly with Zorgvuldig on healthcare policy advisory, public-sector clients, and Dutch-only footprint.
• Vintura: Dutch consultancy specialized in healthcare strategy and transformation for providers, insurers, and government. Highly comparable in target customers, service mix (strategy, policy, transformation support), and Dutch-only focus.
• jb Lorenz: Dutch consultancy specialized in decentralized healthcare procurement and reimbursement (Jeugdwet/Wmo). Partnered with Zorgvuldig on ACM research into market conditions in decentralized care; comparable niche in Dutch healthcare policy advisory.
• Gupta Strategists: Dutch strategy consultancy focused on healthcare, known for policy-oriented reports and provider/insurer advisory. Comparable in serving Dutch healthcare system stakeholders with research-led strategic advice.
• Berenschot: Dutch management consultancy with a large healthcare and public-sector practice. Berenschot is a recurring research partner of Zorgvuldig Advies on Ministry of VWS commissions (e.g., bottom-of-the-pharmaceutical-market study, MedTech sluisonderzoek) and operates in the same Dutch healthcare policy and reimbursement advisory market.
• Panaxea: Dutch healthcare research bureau working on health economics, market access, and policy studies. Partnered with Zorgvuldig on Zorginstituut Nederland audiology research; comparable in commissioned research for Dutch healthcare regulators and payers.
• Andersson Elffers Felix (AEF): Dutch consultancy for public sector and healthcare, focused on policy, organization, and implementation questions. Already collaborates with Zorgvuldig on infectious disease control (IZB) research; directly comparable on Dutch public-sector healthcare advisory.
• IG&H (Intercity Group & Hict): Dutch consultancy dedicated to healthcare providers and insurers, covering strategy, operations, and digital transformation. Directly comparable on customer base (Dutch healthcare), service portfolio, and boutique-to-mid scale.

Broad incumbents

• McKinsey & Company (Netherlands): Global management consultancy with a dedicated healthcare practice in the Netherlands serving ministries, insurers, and large providers. Competes for the same high-level Dutch healthcare strategy and transformation mandates but at far larger scale and broader scope.
• KPMG Netherlands (Healthcare): Big-Four firm with a sizable Dutch healthcare advisory practice covering strategy, operations, and regulatory work. Overlaps with Zorgvuldig on healthcare policy, payer, and provider advisory but as part of a broader portfolio across industries.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zorgvuldig-advies

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zorgvuldig Advies